Shareholders Equity: The sum of preferred and common equity items.
Odonate Therapeutics, Inc. (ODTC) had Shareholders Equity of $136.15M for the most recently reported fiscal year, ending 2020-12-31.
| Income Statement Financials | |
-- |
|
$-126.35M |
|
-- |
|
-- |
|
$127.43M |
|
$-127.43M |
|
$1.08M |
|
$-126.35M |
|
$-126.35M |
|
$-126.35M |
|
$-126.35M |
|
$-126.35M |
|
$-126.35M |
|
$-127.43M |
|
$-126.99M |
|
0.00M |
|
0.00M |
|
$-0.04M |
|
$-0.04M |
|
| Balance Sheet Financials | |
$159.87M |
|
$2.29M |
|
$8.01M |
|
$167.89M |
|
$27.07M |
|
-- |
|
$4.67M |
|
$31.74M |
|
$136.15M |
|
$136.15M |
|
|
Shareholders Equity |
$136.15M |
0.00M |
|
| Cash Flow Statement Financials | |
$-113.13M |
|
$-0.43M |
|
$90.37M |
|
$181.17M |
|
$157.98M |
|
$-23.20M |
|
$9.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-113.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-92.81% |
|
-92.81% |
|
-75.26% |
|
-92.81% |
|
$0.04M |
|
$-0.03M |
|
$-0.03M |
|